pharma · GYRE
GYRE THERAPEUTICS
GYRE THERAPEUTICS, INC.
GYRE THERAPEUTICS patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
SAN DIEGO, CA, USA HQ
Public company Type
GYRE · NYSE Ticker
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, USA
- Programs
- 0
- Drugs
- 0
- Patents
- 0
GYRE THERAPEUTICS patents
0 pharmaceutical patents indexed for GYRE THERAPEUTICS. 0 expire within 24 months.
GYRE THERAPEUTICS has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does GYRE THERAPEUTICS have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do GYRE THERAPEUTICS patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.